Doctor profile · Federal record
Dr. GHAZWAN ACASH, M.D.
Pulmonary Disease Physician (CMS: PULMONARY DISEASE) · Critical Care Medicine (Internal Medicine) Physician · BURLINGTON, MA
- NPI 1710187331
- Accepts Medicare
- 35 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
LAHEY CLINIC, 41 MALL ROAD
BURLINGTON, MA 018050001
(781) 744-8000
Credentials & registration
- NPI registered
- July 2007 — 19 yrs on file
- Profile last updated
- April 5, 2012
- Year of graduation
- 1991 — 35 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State license (1)
- Massachusetts #232254
- Medicaid
- MA #110079208A
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1710187331. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,316
Distinct HCPCS
10
Medicare allowed
$184,372
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99291 |
Critical care, first 30-74 minutes | 421 | 199 | $215 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 172 | 120 | $127 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 121 | 121 | $169 | |
99292 |
Critical care, each additional 30 minutes | 92 | 55 | $107 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 91 | 65 | $80 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 73 | 66 | $93 | |
31624 |
Irrigation and suction of lung airways to obtain cells using an endoscope | 45 | 44 | $66 | |
94060 |
Test to measure expiratory airflow and volume changes before and after medication administration | 37 | 36 | $10 | |
36556 |
Insertion of non-tunneled central venous tube for infusion (5 years or older) | 35 | 31 | $84 | |
94726 |
Test to determine lung volumes using sensors | 35 | 34 | $12 |
In context: peer comparison
Among 12 peers in this city , average services per provider: 66. This provider delivers 20× the peer median.Open Payments
Industry payments received
All-time total
$1,091
Transactions
14
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Gyrus ACMI, Inc. | 1 | $825.00 | |
| AstraZeneca Pharmaceuticals LP | 9 | $181.09 | |
| GENZYME CORPORATION | 1 | $24.39 | |
| Mylan Specialty L.P. | 1 | $21.67 | |
| JAZZ PHARMACEUTICALS INC. | 1 | $21.49 | |
| GlaxoSmithKline, LLC. | 1 | $17.07 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
609
Patients
130
Total drug cost
$351,788
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 106 | 39 | $881 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 96 | 25 | $43,391 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 84 | 31 | $2,651 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 83 | 16 | $61,473 |
| Azithromycin | Generic | 44 | 19 | $786 |
| Breztri Aerosphere (Budesonide/Glycopyr/Formoterol) | Brand | 31 | 0 | $20,524 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 25 | 0 | $13,389 |
| Spiriva Respimat (Tiotropium Bromide) | Brand | 23 | 0 | $18,099 |
| Spiriva Handihaler (Tiotropium Bromide) | Brand | 22 | 0 | $12,092 |
| Montelukast Sodium | Generic | 19 | 0 | $443 |